Keryx Biopharmaceuticals


Keryx Biopharmaceuticals Stock Quote

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Interactive Chart

News & Analysis: Keryx Biopharmaceuticals

The Fool has written over 200 articles on Keryx Biopharmaceuticals.


Market Moves

Keryx Biopharma Down 17% Despite Drug Approval

Shares took a nosedive after the company's earnings report, but with a new FDA approval under its belt, this could be a buying opportunity for investors.

3 Biotech Stocks With Big News Coming

Flexion Therapeutics, Keryx, and Zogenix have market-moving news on deck that could cause shares to soar or plummet in the next few months.